Peptide length and leaving-group sterics influence potency of peptide phosphonate protease inhibitors.
暂无分享,去创建一个
Cheryl A. Tajon | C. Craik | Manisha Ray | P. Egea | A. A. Eroy-Reveles | Christopher M. Brown | A. Eroy-Reveles
暂无分享,去创建一个
Cheryl A. Tajon | C. Craik | Manisha Ray | P. Egea | A. A. Eroy-Reveles | Christopher M. Brown | A. Eroy-Reveles